Alnylam Pharmaceuticals
ALNY
#573
Rank
ยฃ28.53 B
Marketcap
ยฃ221.23
Share price
-2.11%
Change (1 day)
61.49%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company